Bunck M, Diamant M, Corner A et al
La tirzepatida ha demostrado en ensayos clnicos una mayor prdida de peso y mejor control metablico que la semaglutida, resume a SINC Mara Josefa Garca Barrado , profesora de farmacologa de la Universidad de Salamanca, especializada en neuroendocrinologa y obesidad
This usually requires conversion to a belt lipectomy to address the lack of improvement of the flanks, waist, thighs, and buttocks
The reduced incretin effect in type 2 diabetic patients is much more closely related to the losses in insulinotropic activity of GIP, which are typical of this condition, and less so to those related to GLP-1 [64]
S., Mandave, P
doi: 10.1016/j.ghir.2004.06.001 8 GulerHPZapfJSchmidCFroeschER